Wearable microneedle patch tracks antibiotic levels in real time, preclinical tests show

by King Abdullah University of Science and Technology

edited by Gaby Clark, reviewed by Andrew Zinin

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

Wearable devices have transformed how people track exercise, sleep, heart rate and other vital signs. Researchers at King Abdullah University of Science and Technology (KAUST) are now exploring whether similar technologies could one day help monitor medicines inside the body.

In a new study published in Device, KAUST researchers developed a wearable microneedle patch capable of continuously measuring drug levels beneath the skin and wirelessly transmitting the data to a smartphone in real time. The research points toward a future where wearable technologies could provide continuous information about therapies inside the body, not just physical activity and vital signs.

From snapshots to continuous tracking

Today, many medicines that require careful dosing are monitored through periodic blood tests followed by laboratory analysis. These tests provide only a snapshot of drug levels at a particular moment and can take time to process. The KAUST platform was designed to explore whether continuous monitoring could provide a more complete picture of how medicines move through the body over time.

The device uses an array of tiny microneedles that access interstitial fluid just beneath the skin. Combined with miniaturized electronics and Bluetooth connectivity, the system continuously measures drug concentrations and displays the information on a smartphone through a lightweight wearable platform.

Vancomycin as a test case

The researchers demonstrated the technology using vancomycin, an antibiotic commonly used to treat serious infections. Because the drug must be maintained within a relatively narrow concentration range to remain both safe and effective, it provides an ideal test case for technologies designed to continuously monitor medicines.

The complete device weighs just 6.7 grams (0.24 ounces) and combines microneedle sensing, electrochemical biosensors, onboard electronics, wireless communication and smartphone visualization into a single wearable system.

"Wearable technologies have changed the way people monitor many aspects of their health, from physical activity to heart rate and sleep," said Khaled Nabil Salama, professor of electrical and computer engineering and bioengineering at KAUST and lead author of the study. "This research explores whether future wearable devices could also help us understand how medicines behave inside the body. While the technology is still at an early stage, it demonstrates a new approach to monitoring therapies continuously rather than relying on occasional measurements."

Early results and next steps

The researchers tested the platform in laboratory experiments and preclinical studies, where it successfully tracked changing drug concentrations over several hours. While further development and clinical validation will be required before the technology could be used in health care settings, the findings demonstrate the feasibility of continuous wearable drug monitoring using a minimally invasive sensor platform.

Although demonstrated using an antibiotic, the researchers believe the sensing platform could potentially be adapted in the future for other medicines that require careful dose monitoring, helping support more personalized approaches to treatment.

As the team continues to develop the technology, future research will focus on extending monitoring duration, improving long-term stability and evaluating the platform across a broader range of medical applications.

Publication details

Yurii Tsyban et al, Aptamer-based microneedle sensing platform for in vivo drug monitoring, Device (2026). DOI: 10.1016/j.device.2026.101205

Journal information: Device

Key medical concepts

VancomycinFluid, Intercellular

Clinical categories

Clinical pharmacologyInfectious diseases Provided by King Abdullah University of Science and Technology Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Wearable microneedle patch tracks antibiotic levels in real time, preclinical tests show (2026, July 14) retrieved 14 July 2026 from https://medicalxpress.com/news/2026-07-wearable-microneedle-patch-tracks-antibiotic.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.